Chlamydia trachomatis and the risk of spontaneous preterm birth, babies Chlamydia trachomatis and the risk of spontaneous preterm birth, babies who are born small for gestational age, and stillbirth: A population-based who are born small for gestational age, and stillbirth: A population-based cohort study cohort study Abstract Background: Chlamydia trachomatis is one of most commonly diagnosed sexually transmitted infections worldwide but reports in the literature of an association between genital chlamydia infection and adverse obstetric outcomes are inconsistent.
Introduction
Worldwide, chlamydia is one of the most common sexually transmissible infections (STIs) with an estimated 131 million new cases annually; the majority diagnosed in women of childbearing age. 1 While genital infections are thought to contribute to the incidence of adverse obstetric outcomes such as spontaneous preterm birth and stillbirth, 2 there are limited data regarding the role of chlamydia infections on these outcomes. There are no published randomised controlled trials of the effects of chlamydia screening in pregnancy on obstetric outcomes. 3 Furthermore, randomised placebo-controlled prevention trials of antibiotics (including azithromycin) given during the antenatal period to high-risk women have found no effect on the rates of preterm birth. 4 Findings from observational studies have been inconsistent with most, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] but not all, [16] [17] [18] [19] [20] [21] [22] suggesting chlamydia infection increases the risk of preterm birth. There is similar discordance in studies examining the effects of chlamydia infection on birth weight and stillbirth. 9, 23 There are many possible explanations for the discrepancy in findings between published observational studies. These include studies with small numbers of events leading to random error; inconsistency in the type of chlamydia test used (serology, culture or nucleic-acid amplification); variations in the outcome definition and ascertainment; use of case-control designs where control populations may not be well matched; inadequate control of potential confounders including other genital tract infections, or other factors known to result in adverse obstetric outcomes such as smoking during pregnancy; and the potential for publication bias. In this analysis we use a large cohort of women with laboratory chlamydia testing and positivity records and reliable ascertainment of outcomes to examine the effects of chlamydia infection on the risk of spontaneous preterm birth, and other adverse birth outcomes.
Methods

Study population and linkage
A cohort comprising women of reproductive age residing in the Australian state of Western Australia (WA) was constructed by probabilistically linking two wholepopulation administrative datasets; Birth Registrations, which contain a record of all children born and registered in WA from 1974 onwards, and the WA Electoral Roll.
Electoral enrolment is compulsory for Australian citizens with an estimated 92% of the eligible population included on the roll in WA. 24 Linkage accuracy using this process is high with an error rate estimated at 0.11%. 26 All linkage was conducted independent of the study investigators and only deidentified data were provided for analysis.
Outcome definitions
A woman was categorised as having a spontaneous preterm birth if she had a delivery at <37 weeks gestation with spontaneous onset of labour. A small-forgestational-age baby was defined if the infant birth weight was less than the 10 th centile for gestational age by infant sex. Stillbirths (>20 weeks gestational age) were identified in the Midwives Notification System.
Exposure to chlamydia testing and infection
Women were initially categorised according to their history of chlamydia testing in relation to the pregnancy. The date of conception was calculated by subtracting the number of weeks gestation from the date of birthing. Women were classified as 'tested during pregnancy' if the women had at least one chlamydia test during the pregnancy, 'tested prior to pregnancy' if there was no record of a test during pregnancy but at least one chlamydia test record dated prior to the pregnancy, and 'no test record' if there was no linked chlamydia test prior to the date of birthing.
As the risk of adverse outcomes could vary according to when a woman was tested, analyses were then conducted to determine associations between chlamydia positivity and each of the three outcomes taking test timing into account. Women were classified into five categories: tested 'negative' during pregnancy, tested 'positive' during pregnancy, tested 'negative' prior to pregnancy, tested 'positive' prior to pregnancy and no test record with priority given to tests that occurred most proximal to the date of birthing. A three category analysis was also investigated examining the association with chlamydia positivity regardless of the timing of the test (during or prior to pregnancy).
Validity of chlamydia test result was assessed by comparing those testing positive from the pathology data with chlamydia notifications from the WA Notifiable Infectious Diseases Database.
Statistical analyses
Analyses were restricted to women in the cohort who had a first record of a singleton birth (regardless of parity), between 2001 and 2012, in the Midwives Notification System, and were resident in WA and aged ≥15 years at the time of giving birth.
Spontaneous preterm birth versus term birth, small-for-gestational-age versus not, and stillbirth versus live birth were examined separately, however outcomes were not mutually exclusive (e.g. stillbirths could also be classified as born preterm). Those with missing outcome data were excluded from each analysis.
Multivariate logistic regression was used to determine the associations between chlamydia testing and positivity and each of the three outcomes. All regression analyses were initially adjusted for maternal age at delivery (in 5 year age groups), 
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Results
We identified 101,558 women with a first record of a singleton birth between 2001 and 2012 in the cohort. Of births that could be classified, 3921/101558 (3·9%) had a spontaneous preterm birth, 9762/101371 (9·6%) births were small-for-gestationalage and 682/101,558 (0·7%) were stillbirths. Table 1 shows women's characteristics according to birth outcome. Generally, women with each of the adverse obstetric outcomes shared similar characteristics.
They were younger, had lower socioeconomic status, were less likely to be resident in a major city, and less likely to identify as Caucasian than those without the three adverse outcomes. They were also more likely to have smoked during the pregnancy, and to have been diagnosed with hepatitis C, syphilis, gonorrhoea and trichomoniasis during or prior to the pregnancy.
Among the cohort, 21 respectively had a chlamydia notification in the corresponding period. Figure 1 shows the association between chlamydia testing (grouping those with both positive and negative tests together) and each birth outcome evaluated. Compared to women who were tested for chlamydia during their pregnancy, women who only had a record of testing prior to their pregnancy were significantly more likely to have a spontaneous preterm birth (adjusted odds ratio [aOR] 1·15, 95%CI 1·04-1·27, p=0·008). The opposite was observed for small-for-gestational-age, with women tested for chlamydia prior to pregnancy significantly less likely to have a small-forgestational-age baby than those who were tested during pregnancy (aOR 0·86, 95%CI 0·81-0·92, p<·0001). Women tested for chlamydia prior to pregnancy were also substantially more likely to have a stillbirth than those tested for chlamydia during pregnancy (aOR 1·71, 95%CI 1·35-2·17, p<·0001). For each of the three outcomes there was no significant difference in risk between women with no test record and women tested for chlamydia during their pregnancy in the fully adjusted models. Figure 2 shows the association between chlamydia positivity and each adverse obstetric outcome. Among women tested for chlamydia during their pregnancy, 864 (4·5%) who were negative for chlamydia and 81 (6·2%) who were positive for chlamydia had a spontaneous preterm birth. For women who only had a chlamydia test record prior to their pregnancy, 696 (4·1%) test-negative women and 84 (5·5%) test-positive women had a spontaneous preterm birth. In models adjusted for age, region of residence and socioeconomic status, the risk of spontaneous preterm birth in women testing positive versus negative for chlamydia approached, but did not reach statistical significance. However, in the fully-adjusted model, there was no significant association between chlamydia positivity and spontaneous preterm birth.
This was the case for women tested during pregnancy (aOR 1·00, 95%CI 0·79-1·27, p=0·99) and remained regardless of the trimester during which testing occurred (first trimester aOR 1·13, 95%CI 0·82-1·57, p=0·45; second/third trimester aOR 0·88, 95%CI 0·62-1·25, p=0·48) and in women tested only prior to their pregnancy (aOR 1·12, 95%CI 0·89-1·42 p=0·33). The main factors resulting in attenuation of the risks included adjustment for ethnicity, age and other infections (Appendix page 1).
Among women tested during pregnancy, a higher percentage of women with a positive chlamydia test had a small-for-gestational-age baby than those who tested negative (17·1% vs 12·2%). Respective proportions among women only tested for chlamydia prior to their pregnancy were 9·6% vs 8·6%. Similar to results for spontaneous preterm birth, after adjustments, there were no significant differences in the risk of a small-for-gestational-age baby by chlamydia positivity.
There were too few stillbirths to investigate the association with chlamydia positivity stratified by test timing. Twenty-six (0·9%) women with a positive chlamydia test and 277 (0·7%) women who were negative for chlamydia had a stillbirth ( Figure 2 ) and there was no significant association between chlamydia positivity and stillbirth (aOR 0·93, 95%CI 0·61-1·42, p=0·74).
Analyses stratified by Aboriginality, age group and year of giving birth were consistent with the main results for both spontaneous preterm birth and small-forgestational-age (Table 2 ). There was also no significant difference in the risk of spontaneous preterm birth at <34 weeks by chlamydia positivity (see Appendix page 2).
Discussion
This large population-based cohort study analysed more than 20,000 women with laboratory chlamydia testing data during pregnancy. With over 900 cases of spontaneous preterm birth and over 2500 small-for-gestational-age births, we found no increase in the risk of having a spontaneous preterm birth or a small-forgestational-age baby among women with a positive chlamydia test. While there were fewer cases, we also found no evidence to suggest a relationship of a positive chlamydia test and stillbirth.
There has been one systematic review of 7 observational studies 14 and a number of other observational studies examining the association between genital chlamydia infection and preterm birth with equivocal findings reported across studies. As a body of evidence, interpreting these findings collectively is difficult for a number of reasons. Firstly there is a lack of consistent outcome definition. Some studies have not distinguished spontaneous preterm births from all other preterm births 5, 6, 9, 12, 13, 18, 19, [21] [22] [23] and in many high-income countries a substantial proportion of preterm births are planned (by labour induction or prelabour caesarean section) to manage obstetric conditions such as hypertensive diseases. 2 Similarly many studies report on low birth weight without taking into account gestational age and therefore do not clearly distinguish this outcome from preterm birth. 7, 8, 18, 23 Secondly, all of the larger reports prior to this one do not have information on those who tested negative for chlamydia. 13, 15, 21, 23 Thirdly some studies do not consider potential confounders such as the presence of other genital infections, maternal smoking and ethnicity, and therefore have been unable to account for these factors when quantifying associations. 8, 9, 12, 22 Lack of consideration of such factors can lead to false positive results. For example much chlamydia screening has focussed on young women with multiple sexual partners. 3 Younger age is strongly associated with spontaneous preterm birth 15 and young women with multiple sexual partners may be more likely to take part in higher risk activities such as smoking in pregnancy that also increase the risk of adverse obstetric outcomes; hence studies comparing outcomes in positive women to those not tested for chlamydia can be biased. Other differences that may also contribute to the variation in findings include differences in study populations and timing of testing during the pregnancy and the test type.
This study had well-defined and reliably reported outcomes 27 based on a statutory perinatal birth register. We were able to make comparisons between women who tested positive and negative for chlamydia and stratify by timing of tests in relation to the pregnancy. We also took into account other important factors such as ethnicity, maternal smoking and other infections. Furthermore, the cohort design, with ascertainment of outcomes and exposures (chlamydia testing information) from independent sources (perinatal register and pathology data respectively), reduced the likelihood of biased reporting. On systematic searching of the literature, we identified four studies larger than this report to have examined the association between chlamydia infection and preterm birth 13, 21, 22 including one from our research team. 15 However, three lacked information on actual testing for chlamydia (ie. they compared those with a positive chlamydia test to the rest of the population regardless of whether they had been tested for chlamydia) 13, 15, 21 and one casecontrol study assessed chlamydia infection through presence of positive serology (IgG) and found no association of chlamydia with preterm birth. 22 Our findings, of no increase in the risk of preterm birth with a genital chlamydia infection, are plausible and supported by some other observational studies. 11, 17, [19] [20] [21] [22] The substantial attenuation of the risk of any adverse obstetric outcome (including preterm birth) that we found after adjusting for other infections and ethnicity support the notion that studies that reported positive associations between chlamydia infection and preterm birth may be affected by residual confounding. Further, while there are no reported trials of chlamydia screening of women in pregnancy to reduce preterm birth, 3 placebo-controlled trials of prophylactic antibiotics (including azithromycin or erythromycin which are both effective against chlamydia) given to women during the antenatal 4 and preconception period 28 have shown no significant reduction in preterm birth rates. These trial findings suggest that chlamydia is not a major causative organism in preterm birth.
We did not have treatment data however, an audit of General Practitioner (GP) notified chlamydia cases in Western Australia in 2008 found that 91% were prescribed either azithromycin (83%) or doxycycline (9%) 29 and thus we assumed that the majority of women who tested positive were treated for their chlamydia infection. Hence our results should be interpreted in this light. That is, the risk of spontaneous preterm birth is similar between women who tested negative and those who tested positive who were treated. That being said, a significant proportion of the chlamydia diagnosed in our cohort is likely to have been detected through asymptomatic screening 29 and therefore the duration of infection prior to testing and treatment could vary substantially. We found that women who were tested for chlamydia prior to pregnancy, but not during pregnancy, had a greater risk of preterm birth and stillbirth (aOR 1·15 and 1·71 respectively; Figure 1 ) than women who were tested during pregnancy. It is possible that women who were only tested prior to pregnancy could have undiagnosed and hence untreated chlamydia, or other genital infections, during the pregnancy and that the untreated infection (i.e. longer duration) may explain the observed increase in the risk of adverse outcomes.
Alternate explanations could be that these women were less likely to access preventative antenatal care (including chlamydia screening), and it is the reduced access to care that accounts for their higher risk.
Only some observational studies examining the association between chlamydia and preterm birth have reported on treatment. Of those reporting or assuming treatment, some studies found significant associations between chlamydia infection and preterm birth 18, 23 while others were equivocal. 14, 19 Of studies documenting that the chlamydia infections were untreated 5, 6, 16, 17, 30 four suggested an increase in risk of preterm birth but they were all conducted prior to the year 2000 when nucleic-acid testing for chlamydia became widespread. The only study 17 that showed no increase in risk was also the only one to have been conducted after 2000. Future studies of untreated chlamydia infection in pregnancy are unlikely to be ethical however studies where routine post-partum testing for chlamydia (regardless of obstetric outcome) is conducted may identify potentially untreated infections that had been present during pregnancy and assist in establishing whether an untreated infection is itself a risk factor for preterm birth.
While our linked pathology data did not include all tests conducted in the state, 25 our main comparisons are between women who tested positive for chlamydia and those who tested negative. It is conceivable that some women may have been tested at more than one laboratory but our data from the two labs show this was minimal with no women tested at more than one of the labs during pregnancy and less than 10% 14 tested at more than one of the labs in the three years prior to pregnancy. Other caveats on interpreting our findings include the lack of data on NAAT titres that may correlate with severity of infection, and clinical information on whether infections were symptomatic or not. Therefore we could not investigate whether more severe infections themselves are associated with an increased risk of adverse birth outcomes. Nor were we able to examine factors such as effects of host genetic susceptibility. This is the largest study, in the era of widespread nucleic acid testing, to compare the risk of adverse birth outcomes in women with a positive and negative chlamydia test. Our results suggest that a chlamydia infection diagnosed and presumably treated either during or prior to pregnancy does not increase a woman's risk of spontaneous preterm birth, small-for-gestational-age birth or stillbirth. These findings support the continued screening of high risk women during pregnancy for chlamydia and they should reassure women who have chlamydia diagnosed during pregnancy and treated that there is no increased risk of serious adverse birth outcomes. 
